126 related articles for article (PubMed ID: 36327703)
1. A Comparative Study of the Resorption and Immune Response for Two Starch-Based Hemostat Powders.
Capella-Monsonís H; Shridhar A; Chirravuri B; Figucia M; Learn G; Greenawalt K; Badylak SF
J Surg Res; 2023 Feb; 282():210-224. PubMed ID: 36327703
[TBL] [Abstract][Full Text] [Related]
2. Safety and Performance of Hemostatic Powders.
Szymanski L; Gołaszewska K; Małkowska J; Kaczyńska J; Gołębiewska M; Gromadka B; Matak D
Med Devices (Auckl); 2023; 16():133-144. PubMed ID: 37313450
[TBL] [Abstract][Full Text] [Related]
3. Microporous polysaccharide hemosphere absorbable hemostat use in cardiothoracic surgical procedures.
Bruckner BA; Blau LN; Rodriguez L; Suarez EE; Ngo UQ; Reardon MJ; Loebe M
J Cardiothorac Surg; 2014 Aug; 9():134. PubMed ID: 25085116
[TBL] [Abstract][Full Text] [Related]
4. Hemostatic Efficacy and Biocompatibility Evaluation of a Novel Absorbable Porous Starch Hemostat.
Zhu J; Wu Z; Sun W; Meng Z; Zhu X; Gan H; Gu R; Guo X; Dou G
Surg Innov; 2022 Jun; 29(3):367-377. PubMed ID: 34551638
[TBL] [Abstract][Full Text] [Related]
5. A Prospective Analysis of the Effects of a Powder-Type Hemostatic Agent on the Short-Term Outcomes after Liver Resection.
Kang M; Cho JY; Han HS; Yoon YS; Lee HW; Lee B; Park Y; Kim J
Medicina (Kaunas); 2024 Feb; 60(2):. PubMed ID: 38399565
[No Abstract] [Full Text] [Related]
6. Hemostatic efficacy of composite polysaccharide powder (starch-chitosan) for emergency bleeding control: An animal model study.
Mardani M; Eftekharian HR; Naseri M; Hosseini SMH; Mohammadi H; Danesteh H; Ghadimi N; Fazel S
Surgery; 2022 Sep; 172(3):1007-1014. PubMed ID: 35778274
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of resorption and biocompatibility of collagen hemostats in the spinal epidural space.
Mizuno K; Ikeda T; Ikoma K; Ishibashi H; Tonomura H; Nagae M; Arai Y; Fujiwara H; Mikami Y; Kubo T
Spine J; 2014 Sep; 14(9):2141-9. PubMed ID: 24486475
[TBL] [Abstract][Full Text] [Related]
8. Comparative safety and efficacy of topical hemostatic agents in a rat neurosurgical model.
Ereth MH; Schaff M; Ericson EF; Wetjen NM; Nuttall GA; Oliver WC
Neurosurgery; 2008 Oct; 63(4 Suppl 2):369-72; discussion 372. PubMed ID: 18981845
[TBL] [Abstract][Full Text] [Related]
9. A self-gelling starch-based sponge for hemostasis.
Huang W; Wu J; Huang Z; Zhang D; Chen F; Liu C
J Mater Chem B; 2023 Feb; 11(6):1331-1343. PubMed ID: 36655482
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the Hemostatic Efficacy of Two Powdered Topical Absorbable Hemostats Using a Porcine Liver Abrasion Model of Mild to Moderate Bleeding.
MacDonald MH; Tasse L; Wang D; Zhang G; De Leon H; Kocharian R
J Invest Surg; 2021 Nov; 34(11):1198-1206. PubMed ID: 32928005
[TBL] [Abstract][Full Text] [Related]
11. Effects of PerClot® on the healing of full-thickness skin wounds in rats.
Wang Y; Xu M; Dong H; Liu Y; Zhao P; Niu W; Xu D; Ji X; Xing C; Lu D; Li Z
Acta Histochem; 2012 Jul; 114(4):311-7. PubMed ID: 21782216
[TBL] [Abstract][Full Text] [Related]
12. Hemostatic Comparison of a Polysaccharide Powder and a Gelatin Powder.
Singh RK; Baumgartner B; Mantei JR; Parreno RN; Sanders PJ; Lewis KM; Barry JJ
J Invest Surg; 2019 Aug; 32(5):393-401. PubMed ID: 29420097
[No Abstract] [Full Text] [Related]
13. Evaluation of Absorbable Hemostatic Powder for Prevention of Lymphoceles Following Robotic Prostatectomy With Lymphadenectomy.
Gilbert DR; Angell J; Abaza R
Urology; 2016 Dec; 98():75-80. PubMed ID: 27592524
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the Safety and Efficacy of a Novel Thrombin Containing Combination Hemostatic Powder Using a Historical Control.
Bruckner BA; Spotnitz WD; Suarez E; Loebe M; Ngo U; Gillen DL; Manson RJ
Clin Appl Thromb Hemost; 2021; 27():10760296211017238. PubMed ID: 34024165
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of hemostatic matrix and microporous polysaccharide hemospheres.
Lewis KM; Atlee H; Mannone A; Lin L; Goppelt A
J Surg Res; 2015 Feb; 193(2):825-30. PubMed ID: 25266604
[TBL] [Abstract][Full Text] [Related]
16. Prospective randomized study evaluating the effects of PerClot® (Polysaccharide Hemostatic System) application in patients with high bleeding risk undergoing cardiac rhythm device implantation.
Tscholl V; Spann F; Moses J; Nagel P; Bellmann B; Biewener S; Amtenbrink M; Stroux A; Rillig A; Landmesser U; Roser M
Int J Cardiol; 2017 Dec; 248():84-91. PubMed ID: 28843718
[TBL] [Abstract][Full Text] [Related]
17. Comparison of adhesion prevention capabilities of the modified starch powder-based medical devices 4DryField
Poehnert D; Neubert L; Klempnauer J; Borchert P; Jonigk D; Winny M
Int J Med Sci; 2019; 16(10):1350-1355. PubMed ID: 31692813
[TBL] [Abstract][Full Text] [Related]
18. Microvascular anastomosis with minimal suture and Arista: an experimental study.
Benlier E; Top H; Aygit AC; Usta U; Unal Y
J Reconstr Microsurg; 2007 Aug; 23(6):311-5. PubMed ID: 17975772
[TBL] [Abstract][Full Text] [Related]
19. Use of PerClot
Rao K; Gomati A; Yuen Hao Tong E; W Ah-See K; Shakeel M
Eur Arch Otorhinolaryngol; 2021 Jun; 278(6):1965-1969. PubMed ID: 32766929
[TBL] [Abstract][Full Text] [Related]
20. Iota-carrageenan/xyloglucan/serine powders loaded with tranexamic acid for simultaneously hemostatic, antibacterial, and antioxidant performance.
de Moraes FM; Philippi JV; Belle F; da Silva FS; Morisso FDP; Volz DR; Ziulkoski AL; Bobinski F; Zepon ΚM
Biomater Adv; 2022 Jun; 137():212805. PubMed ID: 35929232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
